First Foundation Advisors Pfizer Inc Transaction History

First Foundation Advisors

$2.56 Billion
Q2 2024

A detailed history of First Foundation Advisors transactions in Pfizer Inc stock. As of the latest transaction made, First Foundation Advisors holds 174,692 shares of PFE stock, worth $5.06 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

174,692

Previous 155,951 12.02%

Holding current value

$5.06 Million

Previous $4.33 Million 12.94%

% of portfolio

0.19%

Previous 0.18%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $473,397 - $554,733	18,741 Added 12.02%	174,692 $4.89 Million
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $535,146 - $614,519	20,670 Added 15.28%	155,951 $4.33 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $932,083 - $1.21 Million	-35,671 Reduced 20.87%	135,281 $3.89 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $334,217 - $390,666	10,415 Added 6.49%	170,952 $5.67 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $597,894 - $691,749	16,553 Added 11.5%	160,537 $5.89 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $69,523 - $90,509	1,765 Added 1.24%	143,984 $5.87 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $420,422 - $548,815	-10,070 Reduced 6.61%	142,219 $7.29 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $145,370 - $177,461	-3,322 Reduced 2.13%	152,289 $6.66 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $145,370 - $177,461	-3,322 Reduced 2.13%	152,289 $6.66 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $224,088 - $265,698	-4,816 Reduced 3.0%	155,611 $8.16 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $236,344 - $292,860	-5,166 Reduced 3.12%	160,427 $8.31 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $171,891 - $254,800	-4,160 Reduced 2.45%	165,593 $9.78 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $814,516 - $1.05 Million	-20,752 Reduced 10.89%	169,753 $7.3 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $15.5 Million - $17.6 Million	-431,754 Reduced 69.38%	190,505 $7.46 Million
Q1 2021 May 18, 2021	SELL	$33.49 - $37.77 $278,435 - $314,019	-8,314 Reduced 1.32%	622,259 $22.5 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $385,306 - $489,950	11,512 Added 1.86%	630,573 $23.2 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $945,038 - $1.11 Million	-29,765 Reduced 4.59%	619,061 $22.7 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $543,003 - $658,743	-18,028 Reduced 2.7%	648,826 $21.2 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $213,158 - $304,557	-7,886 Reduced 1.17%	666,854 $21.8 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $3.51 Million - $3.99 Million	-106,688 Reduced 13.65%	674,740 $26.4 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $537,579 - $697,082	16,546 Added 2.16%	781,428 $28.1 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $402,379 - $451,779	-10,881 Reduced 1.4%	764,882 $33.1 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $1.47 Million - $1.61 Million	-39,108 Reduced 4.8%	775,763 $32.9 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $1.2 Million - $1.37 Million	-31,296 Reduced 3.7%	814,871 $35.6 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $1.01 Million - $1.22 Million	-29,167 Reduced 3.33%	846,167 $37.3 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $3.98 Million - $4.24 Million	-120,573 Reduced 12.11%	875,334 $31.8 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $137,436 - $159,445	-4,307 Reduced 0.43%	995,907 $35.3 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $484,997 - $514,598	14,582 Added 1.48%	1,000,214 $36.2 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $15.7 Million - $17.3 Million	-506,230 Reduced 33.93%	985,632 $35.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,491,862	1,491,862 $50.1 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $162B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Account

First Foundation Advisors Pfizer Inc Transaction History